Pharmerica (PMC) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
PharMerica Reports Second Quarter 2016 Results
August 9, 2016 8:02 AM EDTDiversified Pharmacy Businesses Exceeding Managements Expectations
Reaffirms Annual 2016 Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the second quarter ended June 30, 2016.
     2Q16 Results ÂComparison to
2Q15
ÂComparison to
1Q16
 Revenue   $519.6 million  Increase of 4.4%  Decrease of 0.9%  Gross profit   $81.8 million  Increase of 0.7%  Decrease of 0.2%  ... MorePharMerica Corporation Announces Planned Retirement of Chief Financial Officer David W. Froesel, Jr.
August 9, 2016 8:02 AM EDTSearch Process Underway to Identify Successor
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that David W. Froesel Jr., Executive Vice President, Chief Financial Officer and Treasurer, intends to retire from the Company. Mr. Froesel will continue as Chief Financial Officer through the end of September 2016 to ensure a seamless transition. PharMerica... More
